Evidence map›Paper›PMID 25628757›Full record

ArticleMolecular cytogenetics2015

Genomic instability in complicated and uncomplicated Egyptian schistosomiasis haematobium patients.

Amany A Abd El-Aal, Ibrahim R Bayoumy, Maha M A Basyoni, Asmaa A Abd El-Aal, Ashraf M Emran, Magda S Abd El-Tawab, Manal A Badawi, Rabab M Zalat, Tarek M Diab

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Molecular cytogenetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05697224 (Role of Aschistosoma Haematobiumspecific microRNAas Atumor Marker for Early Diagnosis and Prognosis of Bilharzial Bladder Cancer in Eygpt), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05697224 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Role of Aschistosoma Haematobiumspecific microRNAas Atumor Marker for Early Diagnosis and Prognosis of Bilharzial Bladder Cancer in Eygpt

TypeinterventionalSponsorSohag UniversityRan2023 to 2024Enrolled50ConditionsBladder CancerArmsurinary micro RNA detection
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Amany A Abd El-AalParasitology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
Ibrahim R BayoumyParasitology Department, Theodor Bilharz Research Institute, Giza, Egypt.
Maha M A BasyoniParasitology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
Asmaa A Abd El-AalClinical Pathology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
Ashraf M EmranUrosurgery Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
Magda S Abd El-TawabParasitology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
Manal A BadawiPathology Department, National Research Center, Giza, Egypt.
Rabab M ZalatParasitology Department, Theodor Bilharz Research Institute, Giza, Egypt.
Tarek M DiabParasitology Department, Theodor Bilharz Research Institute, Giza, Egypt.
Cairo University · EGTheodor Bilharz Research Institute · EGNational Water Research Center · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundExploration of genetic changes during active Schistosoma infection is important for anticipation and prevention of chronic sequelae. This study aimed to explore the genomic instability in chromosomal and cellular kinetics in Egyptians suffering from uncomplicated active schistosomiasis haematobium infection in addition to chronic schistosomiasis haematobium cases complicated by bilharzial-associated bladder cancer (BAC).

resultsThis study was conducted on 46 schistosomiasis haemotobium cases, 22 were active (Viable S. haematobium eggs in urine samples as detected by microscopy) and 24 were chronic complicated with bladder cancer. Three cytogenetic techniques were applied; the first was quantitative nuclear-morphocytometry by means of which the Feulgen-stained nuclei were analyzed for parameters including shape, size, integrated optical-density and nuclear area. The second was Fluorescent In-Situ Hybridization (FISH) for specific p53gene-locus of chromosome 17 and the third technique was karyotyping. Concerning chronic complicated cases, the mean ± SD of DNA-content in urinary bladder tissue sections was 3.18 ± 0.65. Five samples (20.83%) of bladder tissue sections of chronic complicated cases showed diploid nuclei, 6 urinary bladder tissue samples (25%) were tetraploid, while 13 bladder samples (54.16%) were aneuploid. Epithelial cells of urine samples demonstrated aneuploidy (mean ± SD = 3.74 ± 0.36).Nuclear contents showed high proliferative DNA index in all urinary epithelial cells. In the acute uncomplicated group, nuclear-DNA of urinary epithelial cells was found diploid with mean nuclear-DNA content of 2.2 ± 0.16SD. Half of these diploid smears had a high proliferation index. The difference between nuclear DNA-contents in acute and chronic cases was significant (P = 0.0001). FISH technique for specific p53gene-locus and karyotyping were done on urinary bladder tissue specimens and peripheral blood monocytes of 8 chronic cases respectively. Three samples (37.5%) with invasive BAC had a deletion of the p53 gene. Karyotyping showed three cases out of the 8 chronic schistosomiasis haematobium patients with chromosomal fragmentations.

conclusionsDNA morphometry was valuable in detection of gross genetic changes in urothelial tissues. It is an important prognostic factor in established schistosomiasis haematobium induced bladder malignancy. It has the great advantage of being applicable on urine cells making it suitable for the prediction of a tendency towards genetic instability in active schistosomiasis haematobium patients.

Indexed as

Chromosomal abnormalitiesFISHKaryotypingMorphocytometrySchistosomiasis haematobium

Identifiers

PMID25628757
PMCPMC4307227
OpenAlexW2115888520

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.